Home

Moderna, Inc. - Financial Overview

Ticker - MRNA

Close PriceMarket CapP/E RatioForward P/E RatioImplied Growth*Implied Forward Growth*P/B Ratio
$24.71$9.56B--2.8N/A-11.9+27.2j%0.9

Revenue and Net Income Chart EPS Chart
  Date Revenue Net Income EPS Revenue Change Net Income Change EPS Change
0 2020-12-31 $274.0M $-747.0M $-1.96 N/A N/A N/A
1 2021-12-31 $17.7B $12.2B $30.31 6373.0% -1733.5% -1646.4%
2 2022-12-31 $18.9B $8.4B $21.26 6.4% -31.5% -29.9%
3 2023-12-31 $6.8B $-4.7B $-12.33 -64.2% -156.4% -158.0%
4 2024-12-31 $3.2B $-3.6B $-9.28 -52.6% -24.5% -24.7%
5 TTM 2024-12-31 $3.2B $-3.6B $-9.28 0.0% 0.0% 0.0%
6 Average 1252.5% -389.2% -371.8%




MRNA - Forecast Data



MRNA - Y/Y % Change

  Metric Value
0 Total Assets $14,142M
1 Cash $1,927M
2 Total Liabilities $3,241M
3 Total Debt $747M
4 Total Equity $10,901M
5 Debt to Equity Ratio 0.07
MRNA Balance Sheet Chart



MRNA - Valuation Chart


Valuation Chart

Share Price Treasury Yield Estimates Fair Value (P/E) Fair Value (P/S) Current P/S
$24.71 4.3% Nicks Growth: 8%
Nick's Expected Margin: 10%
FINVIZ Growth: 13%
Nicks: 14
Finviz: 24
Nick's: 1.441 3.0
Basis Year Nicks Valuation Nicks vs Share Price Finviz Valuation Finviz vs Share Price
$8.27 RevPS TTM $11.92 -51.8% $19.79 -19.9%
$5.59 RevPS 2025 $8.05 -67.4% $13.36 -45.9%
$7.68 RevPS 2026 $11.07 -55.2% $18.37 -25.7%